<DOC>
	<DOC>NCT02466412</DOC>
	<brief_summary>The primary objective of this clinical study is to evaluate the pharmacokinetic (PK) profiles of nicotine (rate and amount of nicotine absorbed) after single use of the Carbon Heated Tobacco Product 1.1 Menthol (CHTP 1.1 M) compared to menthol conventional cigarette (mCC) in healthy smokers.</brief_summary>
	<brief_title>Nicotine Pharmacokinetic Profile of the CHTP 1.1 M</brief_title>
	<detailed_description />
	<mesh_term>Nicotine</mesh_term>
	<mesh_term>Menthol</mesh_term>
	<criteria>Subject is Japanese. Subject is at a minimum 23 years of age. Smoking, healthy subject as judged by the Investigator. Subject has smoked for at least the last 3 years Subject smoked at least 10 commercially available mCCs per day over the last 4 weeks. As per Investigator judgment, the subject cannot participate in the study for any reason (e.g., medical, psychiatric, and/or social reason). Subject has received medication within 14 days or within 5 halflives of a drug (whichever is longer) which has an impact on CYP2A6 activity. Female subject is pregnant or breast feeding. Female subject does not agree to use an acceptable method of effective contraception.</criteria>
	<gender>All</gender>
	<minimum_age>23 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>smoking</keyword>
	<keyword>nicotine absorption</keyword>
	<keyword>modified risk tobacco product</keyword>
	<keyword>conventional cigarette</keyword>
	<keyword>Carbon Heated Tobacco Product</keyword>
</DOC>